Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-059887

Chairman and CEO bought 3,000 shares at an average $1.61 ($4,840)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2021-10-05 Purchase +2,000 $1.66 $3,320 10,884,147 D
Niihara Yutaka Chairman and CEO 2021-10-06 Purchase +1,000 $1.52 $1,520 10,885,147 D
Open-market purchases · 3,000 sh · avg $1.61 · $4,840
Loading xslF345X03/doc4.xml…